Sign in Register
Posted On: 17 June 2020 02:30 pm
Updated On: 12 July 2021 01:17 pm

Dr. Muna Al Maslamani - HMC's expert on infectious diseases like COVID-19

Content Writer
Discuss here!
Start a discussion

We've been seeing quite a bit of Dr. Muna Al Maslamani lately in press conferences to discuss the coronavirus (COVID-19) situation in Qatar, so we decided to find out more about this charming medical expert of infectious diseases like the coronavirus (COVID-19), so we can tell you exactly who is she and why we're including her in our 'Who's Who in Qatar' for this week.

Clinical roles and positions in Qatar

Dr. Muna was appointed as Medical Director of Hamad Medical Corporation's (HMC) Communicable Disease Centre (CDC) which identifies and treats infectious diseases like the coronavirus (COVID-19) in January 2017 and is the Assistant Head of Infectious Diseases Division – Medicine Department at HMC's Hamad General Hospital in Qatar. She also holds the position of Senior Consultant in Transplant Infectious Diseases for the Division.

Prof Michael Richmond, Chief Medical Officer at HMC, described Dr, Muna as a great asset to both HMC and the CDC. This is what he had to say to Gulf Times:

“As well as being a highly skilled senior consultant in infectious diseases, Dr. Muna has extensive experience in quality improvement. Her clinical leadership roles have included deputy chair and acting chair of medicine and assistant head, Infectious Disease. She is eminently suited to lead this new and important facility."

In her previous role as Vice Chairperson, Quality and Patient Safety - Medicine Department at HMC, Dr. Muna was an integral member of HMC's corporate quality improvement team. During that time she also completed a year-long HMC Quality Improvement Fellowship. She also served as Assistant Chairperson-Department of Internal Medicine from October 2006 till September 2012, and also Acting Chairperson Department of Internal Medicine till December 2012.

Who's Who in Qatar: Dr. Muna Al Maslamani - HMC's expert on infectious diseases like COVID-19
Image credit: Qabayan FM

Educational background and qualifications

In 2015, Dr. Muna added an MSc in HealthCare Management (RCSI-Bahrain) and IHI Fellowship (Institute of Healthcare Improvement and HMC) to her list of educational achievements which also includes an MBBS (KFU-KSA,1997), Certification Arab Board Medical Specialication-Internal Medicine (CABMS-Internal Medicine - Syria, 2002) and a Certification of Complete HMC - Infectious Disease Fellowship Training Programme (HMC-IDFTP-Qatar, 2006).

Non-clinical roles

Apart from her clinical responsibilities, Dr. Muna holds various administrative and academic positions within and outside of HMC. She is the

  • Fellowship Training Programme Director for Infectious Diseases
  • Associate Program Director for Transitional Year
  • Assistant Professor of Clinical Medicine in Weill Cornell Medicine (since 2008)
  • Chairperson of the Medical Research Committee
  • Vice-Chairperson of the Medical Research Centre
  • Regular speaker and moderator at many Infectious Diseases Conferences
  • Member of various HMC hospital committees
  • Member of the Infectious Diseases Society of America, Transplant Infectious Diseases Society and Immuno-compromised Host Societ

Grants and awards

Over the course of the past five years, Dr. Muna has received three major grants from QNRF’s NPRP cycle totaling $2,308,120.

She has also received several leadership and service awards for her numerous achievements in medicine, and this bears evidence of her passion and commitment towards work and patients.

A role model for many

She is a role model for many and is committed to improving the quality of patient care; she takes necessary steps to motivate others to do the same. Her role as a sponsor for the Clinical Care Improvement Training Programme (CCITP) of Quality Division has produced 27 Quality Improvement Projects to date. She has also received various Intramural and external research grants and was able to partner with international researchers in conducting clinical research with 49 publications till date.

This is what HMC’s Deputy Chief Medical officer, Head of the Infectious Diseases Division, and Chairman of the National Strategic Group on COVID-19 Dr. Mohamed Abdullatif Al Khal has to say about Dr. Muna to Gulf Times:

“Dr. Al Maslamani is a wonderful example of the realisation of our strategy to develop leadership capabilities among our Qatari clinicians. She will be an excellent role model for the next generation of doctors who will lead our healthcare system in the future.”